PP

Pharmacie Pinoy

BE0460.960.034

Gross margin
€ 323K ↓ 8% 2021 Total € 4.43M
Profit
€ 73K ↓ 6% 2021 Total € 924K
EBITDA
€ 117K ↓ 3% 2021 Total € 1.63M
EBIT
€ 107K 2021 Total € 1.33M
Net profit
€ 73K ↓ 6% 2021 Total € 924K
Capex
€ -6K ↓ 184% 2021 Total € 307K
Assets
€ 390K ↑ 2% 2021
Equity
€ 177K ↑ 71% 2021
Debt
€ 213K ↓ 24% 2021
Cash
€ 33K ↓ 66% 2021
Cashflow
€ 83K ↓ 10% 2021 Total € 1.23M
Working capital
€ 160K ↑ 127% 2021
Current ratio
1.75 ↑ 40% 2021
Quick ratio
1.18 ↑ 97% 2021
Working capital ratio
1.75 ↑ 40% 2021
Debt
€ 213K ↓ 24% 2021
Short-term debt
€ 213K ↓ 24% 2021
Long-term debt
€ 201K ↓ 17% 2017
Debt / EBITDA
1.81 ↓ 22% 2021
Solvability
45.4% ↑ 18.4 pt 2021
Long term debt ratio
1.16 ↓ 9% 2017
Gross profitability
47.2% ↓ 42 pt 2021
Net profitability
41.4% ↓ 33.7 pt 2021
Return On Assets (ROA)
18.78 ↓ 7% 2021
Return On Equity (ROE)
41.38 ↓ 45% 2021
Taxes
€ 35K ↑ 375% 2021 Total € 246K
Salaries and Social Security Contributions
€ 5K ↓ 82% 2021 Total € 346K
Employees
3.80 ↓ 14% 2021
Staff cost per employee
€ 1K ↓ 79% 2021
Dividends
€ 78K ↑ 39% 2020 Total € 847K
Dividend payout
100.2% ↑ 0.3 pt 2020